2015
Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Neonatal Intensive Care Unit in the Decade following Implementation of an Active Detection and Isolation Program
Nelson MU, Bizzarro MJ, Baltimore RS, Dembry LM, Gallagher PG. Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Neonatal Intensive Care Unit in the Decade following Implementation of an Active Detection and Isolation Program. Journal Of Clinical Microbiology 2015, 53: 2492-2501. PMID: 26019206, PMCID: PMC4508396, DOI: 10.1128/jcm.00470-15.Peer-Reviewed Original ResearchMeSH KeywordsDNA, BacterialEpidemiological MonitoringFemaleGenetic VariationGenotypeGenotyping TechniquesHumansInfantInfant, NewbornIntensive Care Units, NeonatalMaleMethicillin-Resistant Staphylococcus aureusMolecular EpidemiologyMolecular TypingRetrospective StudiesStaphylococcal InfectionsVirulence FactorsConceptsNeonatal intensive care unitMethicillin-resistant Staphylococcus aureusIntensive care unitMRSA colonizationMolecular epidemiologyCare unitStaphylococcal cassette chromosome mec type IIAccessory gene regulator (agr) groupsMRSA colonization rateToxic shock syndrome toxinAgr group 1Exfoliative toxin AStaphylococcus aureusPotential virulence factor genesVirulence factor genesMRSA infectionSignificant morbidityClinical differencesPatient daysPulsed-field gel electrophoresisToxin AUSA300 strainGroup 1Continued vigilanceInfection
2006
Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State
Held MR, Begier EM, Beardsley DS, Browne FA, Martinello RA, Baltimore RS, McDonald LC, Jensen B, Hadler JL, Dembry LM. Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State. Pediatrics 2006, 118: e212-e215. PMID: 16785290, DOI: 10.1542/peds.2005-2617.Peer-Reviewed Original ResearchConceptsBlood culturesOutside health care facilityBurkholderia cepacia sepsisLife-threatening casesLife-threatening sepsisPatient's blood culturesHealth care facilitiesInfusate contaminationPulsed-field gel electrophoresisFlush solutionCare facilitiesSafe deliverySepsisCompounding pharmaciesBacterial isolatesBurkholderia cepaciaMedicationsPatientsInfusate
1998
Molecular Analysis of Glycopeptide-ResistantEnterococcus faecium Isolates Collected from Michigan Hospitals over a 6-Year Period
Thal L, Donabedian S, Robinson-Dunn B, Chow J, Dembry L, Clewell D, Alshab D, Zervos M. Molecular Analysis of Glycopeptide-ResistantEnterococcus faecium Isolates Collected from Michigan Hospitals over a 6-Year Period. Journal Of Clinical Microbiology 1998, 36: 3303-3308. PMID: 9774583, PMCID: PMC105319, DOI: 10.1128/jcm.36.11.3303-3308.1998.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsBacterial Typing TechniquesChromosomes, BacterialCross InfectionDNA, BacterialDrug Resistance, MicrobialElectrophoresis, Gel, Pulsed-FieldEnterococcus faeciumGene Transfer TechniquesGenes, BacterialGram-Positive Bacterial InfectionsHumansMichiganMolecular EpidemiologyNucleic Acid HybridizationPlasmidsVancomycinConceptsExtended-care facilityPulsed-field gel electrophoresisEnterococcus faecium isolatesFaecium isolatesClonal disseminationVancomycin-resistant E. faeciumStrain typesE. faecium isolatesVancomycin-resistant E. faecium isolatesIntrahospital disseminationSpread of resistanceMichigan hospitalsMajority of isolatesPatientsHospitalClinical isolatesGentamicin resistanceVanA geneErythromycin resistanceE. faeciumVancomycin resistanceType M2VanB genesMolecular relatednessMost isolates